Table 2.
Actual and expected annual ADHD medicine consumption in 2020 and 2021, absolute and relative difference per country in DDD per 1000 inhabitants per day.
| 2020 |
2021 |
|||||||
|---|---|---|---|---|---|---|---|---|
| Consumption |
Difference |
Consumption |
Difference |
|||||
| actual | expected | absolute | relative | actual | expected | absolute | relative | |
| Global | 3.69 | 3.82 | −0.13 | −3.31% | 3.97 | 3.95 | 0.02 | 0.37% |
| Argentina | 0.13 | 0.19 | −0.06 | −31.95% | 0.17 | 0.20 | −0.03 | −14.69% |
| Australia | 10.23 | 10.03 | 0.20 | 1.99% | 12.62 | 11.39 | 1.23 | 10.78% |
| Austria | 1.06 | 1.10 | −0.04 | −3.59% | 1.24 | 1.21 | 0.03 | 2.97% |
| Belgium | 3.57 | 4.02 | −0.45 | −11.05% | 3.93 | 4.32 | −0.39 | −8.99% |
| Brazil | 0.87 | 1.01 | −0.14 | −13.68% | 1.16 | 1.11 | 0.05 | 5.01% |
| Bulgaria | 0.01 | 0.01 | −0.00 | −9.34% | 0.01 | 0.01 | 0.00 | 0.79% |
| Canada | 19.14 | 19.81 | −0.67 | −3.41% | 21.45 | 21.20 | 0.25 | 1.17% |
| China | 0.02 | 0.02 | −0.00 | −21.88% | 0.03 | 0.03 | 0.00 | 2.77% |
| Colombia | 0.01 | 0.00 | 0.01 | 108.51% | 0.01 | 0.00 | 0.01 | 353.11% |
| Croatia | 0.03 | 0.04 | −0.01 | −7.53% | 0.05 | 0.04 | 0.01 | 3.62% |
| Czech Republic | 0.79 | 0.88 | −0.09 | −10.67% | 0.86 | 0.95 | −0.09 | −9.45% |
| Denmark | 13.43 | 13.46 | −0.03 | −0.16% | 15.53 | 14.73 | 0.80 | 5.42% |
| Estonia | 1.00 | 0.97 | 0.03 | 2.47% | 1.24 | 1.30 | −0.06 | −4.33% |
| Finland | 6.69 | 6.60 | 0.09 | 1.41% | 8.61 | 7.74 | 0.87 | 11.21% |
| France | 0.85 | 0.90 | −0.05 | −6.34% | 1.01 | 0.98 | 0.03 | 2.8% |
| Germany | 3.25 | 3.31 | −0.06 | −1.69% | 3.46 | 3.51 | −0.05 | −1.34% |
| Greece | 0.13 | 0.12 | 0.01 | 5.12% | 0.16 | 0.13 | 0.03 | 24.33% |
| Hong Kong | 2.23 | 2.53 | −0.30 | −11.64% | 2.67 | 2.74 | −0.07 | −2.55% |
| Hungary | 0.21 | 0.22 | −0.01 | −7.98% | 0.25 | 0.25 | −0.00 | −0.16% |
| Indonesia | 0.01 | 0.01 | −0.00 | −12.88% | 0.01 | 0.01 | 0.00 | 4.76% |
| Ireland | 1.81 | 1.83 | −0.02 | −0.58% | 2.10 | 2.02 | 0.08 | 4.08% |
| Italy | 0.07 | 0.09 | −0.02 | −14.88% | 0.09 | 0.10 | −0.01 | −10.18% |
| Japan | 1.69 | 1.74 | −0.05 | −2.61% | 1.94 | 1.93 | 0.01 | 0.47% |
| Jordan | 0.03 | 0.03 | −0.00 | −10.7% | 0.04 | 0.04 | 0.01 | 18.13% |
| Korea | 1.04 | 1.06 | −0.02 | −2.17% | 1.31 | 1.15 | 0.16 | 14.49% |
| Latvia | 0.16 | 0.13 | 0.03 | 24.16% | 0.16 | 0.14 | 0.02 | 14.47% |
| Lithuania | 0.10 | 0.10 | −0.00 | −6.34% | 0.12 | 0.12 | 0.00 | 5.96% |
| Luxembourg | 2.17 | 2.26 | −0.11 | −4.28% | 2.32 | 2.19 | 0.13 | 5.83% |
| Malaysia | 0.02 | 0.02 | 0.00 | 12.61% | 0.03 | 0.02 | 0.01 | 36.27% |
| Mexico | 0.41 | 0.44 | −0.03 | −6.35% | 0.39 | 0.42 | −0.03 | −6.45% |
| Netherlands | 9.73 | 9.26 | 0.47 | 5.04% | 11.40 | 9.71 | 1.69 | 17.35% |
| Norway | 14.38 | 14.84 | −0.46 | −3.09% | 17.05 | 16.72 | 0.33 | 1.96% |
| Philippines | 0.01 | 0.01 | −0.00 | −31.43% | 0.01 | 0.01 | −0.00 | −24.98% |
| Poland | 0.32 | 0.35 | −0.03 | −8.28% | 0.41 | 0.38 | 0.03 | 8.4% |
| Portugal | 2.30 | 2.77 | −0.47 | −17.27% | 2.73 | 2.93 | −0.20 | −6.9% |
| Romania | 0.13 | 0.18 | −0.05 | −27.17% | 0.14 | 0.20 | −0.06 | −31.83% |
| Singapore | 0.50 | 0.50 | −0.00 | −0.73% | 0.52 | 0.53 | −0.01 | −1.95% |
| Slovakia | 0.18 | 0.20 | −0.02 | −10.24% | 0.18 | 0.21 | −0.03 | −14.09% |
| Slovenia | 0.53 | 0.61 | −0.08 | −13.26% | 0.62 | 0.64 | −0.02 | −3.13% |
| South Africa | 1.59 | 2.03 | −0.44 | −21.87% | 1.60 | 2.14 | −0.54 | −25.49% |
| Spain | 3.26 | 3.47 | −0.21 | −6.12% | 3.66 | 3.63 | 0.03 | 0.87% |
| Sweden | 18.53 | 18.12 | 0.41 | 2.30% | 20.17 | 19.38 | 0.80 | 4.12% |
| Switzerland | 6.17 | 6.11 | 0.06 | 1.06% | 7.01 | 6.37 | 0.64 | 10.11% |
| Taiwan | 1.29 | 1.20 | 0.09 | 6.85% | 1.45 | 1.28 | 0.17 | 13.31% |
| Turkey | 1.12 | 1.36 | −0.24 | −17.68% | 1.23 | 1.46 | −0.23 | −15.84% |
| UK | 2.83 | 2.92 | −0.09 | −2.83% | 3.23 | 3.11 | 0.12 | 3.76% |
| US | 30.52 | 31.34 | −0.82 | −2.64% | 32.09 | 31.99 | 0.10 | 0.33% |
| ∅ (winsorized) | −6.20% | 1.60% | ||||||
DDD = defined daily dose. Source: IQVIA MIDAS Quarterly Sales data Q1 2014–Q4 2021.